Rodman & Renshaw 21st Annual Global Investment Conference

September 10, 2019 • 4:40pm EDT

Lotte New York Palace Hotel - Holmes I (4th Floor)

2019 ASCO Annual Meeting

May 31–June 4, 2019

McCormick Place, in Chicago

AACR Annual Meeting

April 2, 2019 • 1:00pm - 5:00pm EDT

Georgia World Congress Center, Exhibit Hall B, Poster Section 10

11th Targeted-Alpha-Therapy International Symposium (TAT)

April 1–April 4, 2019

Ottawa, Canada

Oppenheimer & Co. 29th Annual Healthcare Conference

March 20, 2019 • 1:35pm EDT

Westin Grand Central Hotel - 212 East 42nd St, New York City

2019 Transplantation & Cellular Therapy Annual Meeting

February 20–February 24, 2019

Houston, Texas

Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T

February 7, 2019 • 8:00am - 9:30am EDT

New York City

NobleConXV - Noble Capital Markets' Fifteenth Annual Investor Conference

January 29, 2019 • 12:30pm EDT

W Hotel, Fort Lauderdale, Florida | Studio 4

Biotech Showcase™ 2019

January 7, 2019 • 10:00am PDT

Hilton San Francisco Union Square, San Francisco, CA

30th Annual Piper Jaffray Healthcare Conference

November 27, 2018 • 2:10pm EDT

Lotte New York Palace Hotel, New York, NY

BIO-Europe® 24th Annual International Partnering Conference

November 6, 2018 • 9:00am CET

Bella Center Copenhagen, Copenhagen, Denmark - Room B2 on level 0

Conference Call and Webcast

October 26, 2018 • 11:00am EDT

Webcast

Company Update - Next Generation Lymphodepletion Technology for CAR-T Conditioning

September 26, 2018 • 3:15pm CDT

Webcast

Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease

September 26–September 27, 2018

The Langham Hotel, New York, NY

Maxim Rights Offering Conference

September 6, 2018

New York, NY

2018 B. Riley FBR Healthcare Conference

September 4, 2018 • 12:50pm EDT

New York Marriott East Side, New York, NY - Stuyvesant Room

Iomab-B DMC Update Conference Call

August 15, 2018 • 9:00am EDT

Webcast

Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients Webcast

July 10, 2018 • 8:00am EDT

Webcast

19th Annual Bio€quity Europe Conference

May 15, 2018 • 4:20pm CEST

Het Pand Convention Center, Ghent, Belgium

American Association for Cancer Research Annual Meeting (AACR)

April 14–April 18, 2018

Chicago, IL

28th Annual Oppenheimer Healthcare Conference

March 20, 2018 • 1:00pm EDT

The Westin New York Grand Central, New York, NY

30th Annual ROTH Conference

March 13, 2018 • 1:00am PDT

The Ritz Carlton, Laguna Niguel, Dana Point, CA

CD33 Program Expansion: Actimab-A + CLAG-M Conference Call

February 13, 2018 • 4:30pm EDT

Webcast

BIO CEO & Investor Conference

February 12–February 13, 2018

New York Marriott Marquis, 1535 Broadway, New York, NY 10036

Biotech Showcase™ 2018

January 8, 2018 • 10:00am PDT

Hilton San Francisco Union Square, San Francisco, CA

2017 Annual Meeting of Stockholders

December 20, 2017 • 9:30am EDT

The Garden City Hotel - Garden City, NY

Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz

December 5, 2017 • 8:00am EDT

Webcast

BIO Investor Forum

October 17, 2017 • 3:00pm PDT

Westin St. Francis Horel, San Francisco, CA

Hematologic Oncology 2017 Annual Meeting (SOHO)

September 13–September 16, 2017

Westin Galleria & Oaks, Houston, TX

Rodman & Renshaw 19th Annual Global Investment Conference

September 12, 2017 • 5:30pm EDT

Lotte New York Palace Hotel, New York, NY

Oppenheimer Boston Oncology Insight Summit

August 16–August 17, 2017

Four Seasons Hotel, Boston, MA

Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies

July 13, 2017 • 8:00am EDT

Webcast

Webinar to Provide Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

June 12, 2017 • 8:00am EDT

Webcast

10th International Symposium on Targeted Alpha Therapy (TAT10)

May 31, 2017

Kanazawa University, Kanazawa, Japan

4th Annual Summit on Hematologic Malignancies

March 30–April 1, 2017

Fairmont Chateau Whistler, British Columbia, Canada

Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 2017

March 17–March 18, 2017

Chicago, Illinois

29th Annual ROTH Conference

March 13, 2017 • 3:30pm PDT

The Ritz-Carlton Laguna Niguel, Dana Point, CA

BMT Tandem Meetings

February 22–February 26, 2017

Gaylord Palms Convention Center, Orlando, Florida

Dr. Jeffrey E. Lance, Moffitt Cancer Center – Maximizing Outcomes with Allogeneic HCT in AML Peerview

Dr. Sergio Giralt, Memorial Sloan Kettering – Update on Hematologic Malignancies, New Targeted Conditioning Regimens Bloodline

Source Capital Group’s 2017 Disruptive Growth & Healthcare Conference

February 16, 2017 • 9:00am EDT

Track 1 – Tribeca Room, the Convene, New York, New York

BIO CEO & Investor Conference

February 13, 2017 • 10:00am EDT

New York, New York

3rd Annual Think Tank on Integrating New Molecular Targets in Acute Leukemias and Myeloproliferative Neoplasms

January 27–January 28, 2017

Dallas, Texas

17th Annual ASH Review

January 25, 2017

Cleveland, Ohio

Mayo Clinic Hematology Review

January 21, 2017

Minneapolis, Minnesota

9th Annual Biotech Showcase

January 10, 2017 • 2:00pm PDT

Hilton San Francisco Union Square

Sponsored Webinar: Stem Cell Transplants for AML: What You Need to Know

December 14, 2016 • 7:30pm EDT

LD Micro IX Annual Main Event Conference

December 6, 2016 • 11:30am PDT

Luxe Sunset Boulevard Hotel, Los Angeles, CA

American Society of Hematology Annual Meeting

December 5, 2016 • 6:00pm - 8:00pm PDT

San Diego, CA

Actimab-A Phase 2 Clinical Trial Update

September 27, 2016 • 9:00am EDT

Ladenburg Thalmann 2nd Annual Healthcare Conference

September 27, 2016 • 1:00pm EDT

Sofitel Hotel, New York, NY